{
    "clinical_study": {
        "@rank": "75673", 
        "arm_group": [
            {
                "arm_group_label": "Group 1", 
                "arm_group_type": "Experimental", 
                "description": "VX-661 + ivacaftor\nVX-661 placebo + ivacaftor placebo\n(every 12 hours [q12h] schedule)"
            }, 
            {
                "arm_group_label": "Group 2", 
                "arm_group_type": "Experimental", 
                "description": "VX-661 + ivacaftor\nVX-661 placebo + ivacaftor placebo\n(once daily [qd] and q12h schedule)"
            }
        ], 
        "brief_summary": {
            "textblock": "The objective of this study is to evaluate the safety and efficacy of VX-661in combination\n      with ivacaftor in subjects with cystic fibrosis (CF) who are homozygous for F508del CFTR\n      (cystic fibrosis transmembrane conductance regulator) mutation"
        }, 
        "brief_title": "Study to Evaluate Safety and Efficacy of VX-661 in Combination With Ivacaftor in Subjects With Cystic Fibrosis, Homozygous for the F508del-CFTR Mutation", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Cystic Fibrosis", 
        "condition_browse": {
            "mesh_term": [
                "Cystic Fibrosis", 
                "Fibrosis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Male or female, 18 years or older\n\n          -  Homozygous for the F508del CFTR mutation\n\n          -  FEV1 \u226540% and \u226490% of predicted normal for age, sex, and height\n\n          -  Stable CF disease as judged by the investigator.\n\n        Exclusion Criteria:\n\n          -  History of any comorbidity that, in the opinion of the investigator, might confound\n             the results of the study or pose an additional risk in administering study drug to\n             the subject\n\n          -  Pregnant and nursing females: Females of childbearing potential must have a negative\n             pregnancy test at screening and Day 1\n\n          -  Sexually active subjects of reproductive potential who are not willing to follow the\n             contraception requirements\n\n          -  The subject or a close relative of the subject is the investigator or a sub\n             investigator, research assistant, pharmacist, study coordinator, or other staff\n             directly involved with the conduct of the study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "60", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 21, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02070744", 
            "org_study_id": "VX13-661-103"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Group 2", 
                    "Group 1"
                ], 
                "intervention_name": "VX-661", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Group 2", 
                    "Group 1"
                ], 
                "intervention_name": "ivacaftor", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Group 2", 
                    "Group 1"
                ], 
                "intervention_name": "VX-661 placebo", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Group 2", 
                    "Group 1"
                ], 
                "intervention_name": "ivacaftor placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": "CF", 
        "lastchanged_date": "June 2, 2014", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Birmingham", 
                        "country": "United States", 
                        "state": "Alabama"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Stanford", 
                        "country": "United States", 
                        "state": "California"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Altamonte Springs", 
                        "country": "United States", 
                        "state": "Florida"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Miami", 
                        "country": "United States", 
                        "state": "Florida"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Orlando", 
                        "country": "United States", 
                        "state": "Florida"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Tampa", 
                        "country": "United States", 
                        "state": "Florida"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boise", 
                        "country": "United States", 
                        "state": "Idaho"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Chicago", 
                        "country": "United States", 
                        "state": "Illinois"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Boston", 
                        "country": "United States", 
                        "state": "Massachusetts"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New Brunswick", 
                        "country": "United States", 
                        "state": "New Jersey"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "New York", 
                        "country": "United States", 
                        "state": "New York"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Durham", 
                        "country": "United States", 
                        "state": "North Carolina"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Cincinnati", 
                        "country": "United States", 
                        "state": "Ohio"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oklahoma City", 
                        "country": "United States", 
                        "state": "Oklahoma"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Pittsburgh", 
                        "country": "United States", 
                        "state": "Pennsylvania"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Charleston", 
                        "country": "United States", 
                        "state": "South Carolina"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Memphis", 
                        "country": "United States", 
                        "state": "Tennessee"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Houston", 
                        "country": "United States", 
                        "state": "Texas"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Colchester", 
                        "country": "United States", 
                        "state": "Vermont"
                    }
                }, 
                "status": "Recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Seattle", 
                        "country": "United States", 
                        "state": "Washington"
                    }
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Milwaukee", 
                        "country": "United States", 
                        "state": "Wisconsin"
                    }
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Phase 2, Randomized, Multicenter, Double Blind, Placebo Controlled Study to Evaluate Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of VX-661 in Combination With Ivacaftor for 12 Weeks in Subjects With Cystic Fibrosis, Homozygous for the F508del CFTR Mutation", 
        "overall_contact": {
            "email": "medicalinfo@vrtx.com", 
            "last_name": "Medical Monitor", 
            "phone": "617.341.6777"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Safety as determined by adverse events (AEs), physical examination, clinical laboratory values, standard digital electrocardiograms (ECGs), vital signs and pulse oximetry", 
            "safety_issue": "Yes", 
            "time_frame": "baseline through Week 16"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02070744"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Absolute change in percent predicted forced expiratory volume in 1 second (FEV1)", 
                "safety_issue": "No", 
                "time_frame": "from basline through Week 12"
            }, 
            {
                "measure": "Relative change in percent predicted FEV1", 
                "safety_issue": "No", 
                "time_frame": "from baseline through Week 12"
            }, 
            {
                "measure": "Absolute change in body weight", 
                "safety_issue": "No", 
                "time_frame": "from baseline at Week 12"
            }, 
            {
                "measure": "Absolute change in body mass index (BMI)", 
                "safety_issue": "No", 
                "time_frame": "from baseline at Week 12"
            }, 
            {
                "measure": "Absolute change in the respiratory domain of the Cystic Fibrosis Questionnaire-Revised (CFQ-R)", 
                "safety_issue": "No", 
                "time_frame": "baseline through Week 12"
            }, 
            {
                "measure": "PK parameters estimates of VX 661 and ivacaftor and their respective metabolites, derived from plasma concentration-time data", 
                "safety_issue": "No", 
                "time_frame": "Day 1 through Week 16"
            }, 
            {
                "measure": "Absolute change in sweat chloride", 
                "safety_issue": "No", 
                "time_frame": "from baseline through Week 12"
            }
        ], 
        "source": "Vertex Pharmaceuticals Incorporated", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Vertex Pharmaceuticals Incorporated", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "March 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2014"
    }
}